TABLE 2.
E. colistrain | β-Lactam MIC (μg/ml) |
|||||||
---|---|---|---|---|---|---|---|---|
Cefoxitin | Cefuroxime | Cefotaxime | Ceftazidime | Cefepime | Imipenem | Ertapenem | Meropenem | |
TOP10(pCMY-2)a | 128 | 128 | 128 | 256 | 1 | 0.5 | 0.064 | 0.064 |
TOP10(pACT-1)a | 512 | 512 | 64 | 128 | 0.25 | 0.25 | 0.016 | 0.032 |
TOP10(pDHA-1)a | 32 | 128 | 8 | 64 | 0.064 | 0.25 | 0.012 | 0.032 |
TOP10(pFOX-1)a | 512 | 256 | 16 | 64 | 0.5 | 0.25 | 0.032 | 0.125 |
TOP10(pACC-1)a | 2 | 1 | 1 | 8 | 0.125 | 0.125 | 0.006 | 0.032 |
TOP10(pAmpC-B2)a | 128 | 128 | 0.5 | 1 | 0.06 | 0.125 | 0.064 | 0.032 |
TOP10 | 2 | 1 | 0.06 | 0.06 | 0.06 | 0.125 | 0.006 | 0.032 |
HB4(pCMY-2)a | >512 | >512 | 256 | >512 | 16 | 32 | 256 | 8 |
HB4(pACT-1)a | >512 | >512 | 64 | >512 | 4 | 16 | 256 | 4 |
HB4(pDHA-1)a | >512 | >512 | 128 | 256 | 2 | 2 | 16 | 1 |
HB4(pFOX-1)a | >512 | >512 | 32 | 512 | 8 | 0.5 | 4 | 0.75 |
HB4(pACC-1)a | 256 | 128 | 4 | 16 | 4 | 0.5 | 2 | 0.5 |
HB4(pAmpC-B2) | 512 | 512 | 4 | 8 | 1 | 0.5 | 2 | 0.032 |
HB4 | 256 | 32 | 4 | 4 | 1 | 0.25 | 1 | 0.032 |
E. coli TOP10(pCMY-2), E. coli TOP10(pACT-1), E. coli TOP10(pDHA-1), E. coli TOP10(pFOX-1), E. coli TOP10(pACC-1), and E. coli TOP10(pAmpC-B2) produced CMY-2, ACT-1, DHA-1, FOX-1, ACC-1, and the chromosome-borne cephalosporinase of E. coli EC6. E. coli HB4(pCMY-2), E. coli HB4(pACT-1), E. coli HB4(pDHA-1), E. coli HB4(pFOX-1), E. coli HB4(pACC-1), and E. coli HB4(pAmpC-B2) produced CMY-2, ACT-1, DHA-1, FOX-1, ACC-1, and the chromosome-borne cephalosporinase of E. coli EC6.